nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—HRH1—Histamine receptors—HRH3—narcolepsy	0.218	0.281	CbGpPWpGaD
Alimemazine—HRH1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0338	0.0436	CbGpPWpGaD
Alimemazine—Cyamemazine—HTR2A—narcolepsy	0.0209	0.093	CrCbGaD
Alimemazine—HRH1—Monoamine GPCRs—HTR2A—narcolepsy	0.0201	0.0259	CbGpPWpGaD
Alimemazine—Cyclobenzaprine—HTR2A—narcolepsy	0.0194	0.0865	CrCbGaD
Alimemazine—HRH1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0184	0.0238	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0184	0.0238	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0178	0.0229	CbGpPWpGaD
Alimemazine—HRH1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0169	0.0218	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0165	0.0212	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0165	0.0212	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0159	0.0205	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—HCRT—narcolepsy	0.0151	0.0195	CbGpPWpGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0142	0.0184	CbGpPWpGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0142	0.0184	CbGpPWpGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0138	0.0177	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0135	0.0174	CbGpPWpGaD
Alimemazine—Acepromazine—HTR2A—narcolepsy	0.0134	0.0598	CrCbGaD
Alimemazine—Thioproperazine—HTR2A—narcolepsy	0.0131	0.0584	CrCbGaD
Alimemazine—Pipotiazine—HTR2A—narcolepsy	0.0129	0.0575	CrCbGaD
Alimemazine—Mesoridazine—HTR2A—narcolepsy	0.0127	0.0567	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0122	0.0157	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0122	0.0157	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0118	0.0152	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—TRH—narcolepsy	0.0115	0.0148	CbGpPWpGaD
Alimemazine—Propiomazine—HTR2A—narcolepsy	0.0107	0.0478	CrCbGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0103	0.0132	CbGpPWpGaD
Alimemazine—Clomipramine—HTR2A—narcolepsy	0.0102	0.0454	CrCbGaD
Alimemazine—Chlorprothixene—HTR2A—narcolepsy	0.0102	0.0452	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.01	0.0129	CbGpPWpGaD
Alimemazine—Thioridazine—HTR2A—narcolepsy	0.00961	0.0428	CrCbGaD
Alimemazine—Trimipramine—HTR2A—narcolepsy	0.00938	0.0418	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.00929	0.012	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.00929	0.012	CbGpPWpGaD
Alimemazine—Methotrimeprazine—HTR2A—narcolepsy	0.00917	0.0409	CrCbGaD
Alimemazine—Promethazine—HTR2A—narcolepsy	0.00904	0.0403	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.00897	0.0116	CbGpPWpGaD
Alimemazine—Doxepin—HTR2A—narcolepsy	0.00894	0.0398	CrCbGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00893	0.0115	CbGpPWpGaD
Alimemazine—Trifluoperazine—HTR2A—narcolepsy	0.00892	0.0397	CrCbGaD
Alimemazine—Perphenazine—HTR2A—narcolepsy	0.00882	0.0393	CrCbGaD
Alimemazine—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.00833	0.0107	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.00833	0.0107	CbGpPWpGaD
Alimemazine—Desipramine—HTR2A—narcolepsy	0.00821	0.0366	CrCbGaD
Alimemazine—Promazine—HTR2A—narcolepsy	0.00795	0.0354	CrCbGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00777	0.01	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.00763	0.00984	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00759	0.00979	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00745	0.00961	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00745	0.00961	CbGpPWpGaD
Alimemazine—Chlorpromazine—HTR2A—narcolepsy	0.007	0.0312	CrCbGaD
Alimemazine—Imipramine—HTR2A—narcolepsy	0.00696	0.031	CrCbGaD
Alimemazine—Amitriptyline—HTR2A—narcolepsy	0.00692	0.0308	CrCbGaD
Alimemazine—HRH1—GPCR ligand binding—PENK—narcolepsy	0.0068	0.00877	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00666	0.00858	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—TRH—narcolepsy	0.00578	0.00745	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00552	0.00711	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00552	0.00711	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00525	0.00677	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00525	0.00677	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.00507	0.00654	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.00507	0.00654	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00501	0.00646	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.00477	0.00615	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.00477	0.00615	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.0046	0.00594	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00448	0.00578	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.00431	0.00556	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—NPS—narcolepsy	0.0042	0.00542	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.0042	0.00542	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.00391	0.00505	CbGpPWpGaD
Alimemazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00387	0.00499	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.00384	0.00495	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PENK—narcolepsy	0.00349	0.0045	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00332	0.00428	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.00327	0.00421	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—TRH—narcolepsy	0.00297	0.00383	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	0.00286	0.00369	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	0.00282	0.00363	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	0.00282	0.00363	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—P2RY11—narcolepsy	0.00272	0.00351	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HRH3—narcolepsy	0.0026	0.00335	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	0.00253	0.00326	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	0.00237	0.00306	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—NPS—narcolepsy	0.00237	0.00306	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HCRT—narcolepsy	0.00231	0.00298	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—NPS—narcolepsy	0.00216	0.00278	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—TAC1—narcolepsy	0.00216	0.00278	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PENK—narcolepsy	0.00206	0.00266	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TRH—narcolepsy	0.00175	0.00226	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HRH3—narcolepsy	0.00154	0.00198	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CHKB—narcolepsy	0.00149	0.00192	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	0.00143	0.00184	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	0.0013	0.00167	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TAC1—narcolepsy	0.00127	0.00164	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NPS—narcolepsy	0.00127	0.00164	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CPT1B—narcolepsy	0.00101	0.0013	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HTR2A—narcolepsy	0.000766	0.000988	CbGpPWpGaD
